Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Neutralising antibodies to sclerostin (Scl-Ab) have shown significant potential to induce bone formation and decrease bone resorption, increase strength and substantially reduce fracture risk in animal studies and clinical trials. |